Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 582.6 INR -2.13% Market Closed
Market Cap: 141.2B INR
Have any thoughts about
Granules India Ltd?
Write Note

Granules India Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Granules India Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Granules India Ltd
NSE:GRANULES
Additional Paid In Capital
â‚ą1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
86%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Additional Paid In Capital
â‚ą421.2m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Granules India Ltd
Glance View

Market Cap
141.2B INR
Industry
Pharmaceuticals

Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 3,686 full-time employees. The firm operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The firm has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The company has over seven manufacturing facilities, approximately six of which are located in India and one in the United States. The firm sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

GRANULES Intrinsic Value
509.49 INR
Overvaluation 13%
Intrinsic Value
Price

See Also

What is Granules India Ltd's Additional Paid In Capital?
Additional Paid In Capital
1.5B INR

Based on the financial report for Jun 30, 2024, Granules India Ltd's Additional Paid In Capital amounts to 1.5B INR.

What is Granules India Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
86%

Back to Top